Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.
about
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@en
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@nl
type
label
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@en
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@nl
prefLabel
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@en
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@nl
P2093
P50
P1476
Impact of Alemtuzumab Scheduli ...... bine and Melphalan Allografts.
@en
P2093
Anne M Dickinson
Graham Jackson
Karl S Peggs
Kile Green
Kim Pearce
Kirsty Thomson
Laura Jardine
Matthew Collin
Rob S Sellar
Sandeep Nagra
P304
P356
10.1016/J.BBMT.2017.02.007
P577
2017-02-14T00:00:00Z